HDL-C promotes cholesterol accumulation in tumor cell membranes, enhancing epidermal growth factor receptor (EGFR) signaling—an effect more commonly seen in adenocarcinomas in the lower lobes (31, 32). The gene discussed is EGFR; the disease is adenocarcinoma.